Although there is still no cure for MS, effective strategies are available to modify the disease course, treat exacerbations (also called attacks, relapses, or flare-ups), manage symptoms, improve function and safety, and provide emotional support. In combination, these treatments enhance the quality of life for people living with MS.

Modifying the Disease Course

The following agents can reduce disease activity and disease progression for many individuals with relapsing forms of MS, including those with secondary progressive disease who continue to have relapses.


FDA-Approved Disease-Modifying Agents

Avonex (interferon beta-1a)

Betaseron (interferon beta-1b)

Copaxone (glatiramer acetate)

Extavia (interferon beta-1b)

Gilenya (fingolimod)

Novantrone (mitoxantrone)

Rebif (interferon beta-1a)

Tysabri (natalizumab)

Tefidera (dimethyl-fumarate)

Aubagio (teriflunomide)



Symptom Management

 At LSU, we are expert in the evaluation and management of the following symptoms that are commonly associated with multiple sclerosis:

  • Fatigue
  • Bladder problems
  • Cognitive problems
  • Depression
  • Gait safety
  • Muscle spasticity
  • Low vision
  • Sexual dysfunction
  • Pain

For some of these conditions, we partner with other physicians specialists at LSU who also have expertise in the management of particular MS symptoms.


We are committed to a wellness approach in our clinic, and emphasize the following wellness goals for our MS patients.  

  • Smoking cessation
  • Healthful, low-fat diet
  • Exercise
  • Stress-reduction
  • Retention of employment (whenever possible)
  • Wheelchair access / community access